Matches in Wikidata for { <http://www.wikidata.org/entity/Q74275314> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q74275314 description "clinical trial" @default.
- Q74275314 description "ensayu clínicu" @default.
- Q74275314 description "klinisch onderzoek" @default.
- Q74275314 description "клінічне випробування" @default.
- Q74275314 description "կլինիկական փորձարկում" @default.
- Q74275314 name "Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole" @default.
- Q74275314 name "Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole" @default.
- Q74275314 type Item @default.
- Q74275314 label "Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole" @default.
- Q74275314 label "Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole" @default.
- Q74275314 prefLabel "Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole" @default.
- Q74275314 prefLabel "Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole" @default.
- Q74275314 P1050 Q74275314-AD9A5313-30B3-42AA-9E1D-55B041DEF4BD @default.
- Q74275314 P1050 Q74275314-F11B304F-EE21-4E4D-9160-B6050451C82C @default.
- Q74275314 P1132 Q74275314-F09E03C9-A92B-4CFA-9C19-60CE9790EEB7 @default.
- Q74275314 P1476 Q74275314-508F06F0-CB94-44C8-8D1F-5C54C7F74D90 @default.
- Q74275314 P17 Q74275314-E26EC587-824C-47A6-B011-31E8121D1DA0 @default.
- Q74275314 P2899 Q74275314-B677346D-0749-4E57-9CC8-109C132E9B1D @default.
- Q74275314 P3098 Q74275314-C7921EAE-2EC7-4763-AAF3-525711B22814 @default.
- Q74275314 P31 Q74275314-EA89D03C-0C76-4498-BFCA-366E17FC64E1 @default.
- Q74275314 P580 Q74275314-7B8E897A-F45A-41DD-93E2-738EBF61BA7B @default.
- Q74275314 P582 Q74275314-523EDEF5-CB86-4FAC-A26B-B64FEA08FCB8 @default.
- Q74275314 P6099 Q74275314-5FABC28D-A7C3-4FDE-A917-A3AB49886B82 @default.
- Q74275314 P8363 Q74275314-B5DAAE29-7F95-4BAC-B5AA-D8B39D90DDA8 @default.
- Q74275314 P1050 Q18554884 @default.
- Q74275314 P1050 Q2282783 @default.
- Q74275314 P1132 "+3" @default.
- Q74275314 P1476 "Phase I Study of Sequestered Transscleral, Controlled-Release Celecoxib Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or Vitreous" @default.
- Q74275314 P17 Q30 @default.
- Q74275314 P2899 "+18" @default.
- Q74275314 P3098 "NCT04120636" @default.
- Q74275314 P31 Q30612 @default.
- Q74275314 P580 "2019-09-18T00:00:00Z" @default.
- Q74275314 P582 "2020-10-30T00:00:00Z" @default.
- Q74275314 P6099 Q5452194 @default.
- Q74275314 P8363 Q78089383 @default.